News

TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich, has entered its first clinical trial in patients. Following a successful phase 1a ...
Why AdFalciVax is relevant to the UPSC exam? What is the significance of topics such as State of the Economy, critical ...